Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Long-Term Deferred Tax (2021 - 2025)

Historic Long-Term Deferred Tax for Bioventus (BVS) over the last 3 years, with Q3 2025 value amounting to $4.7 million.

  • Bioventus' Long-Term Deferred Tax fell 3584.37% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year decrease of 3584.37%. This contributed to the annual value of $4.7 million for FY2024, which is N/A changed from last year.
  • Bioventus' Long-Term Deferred Tax amounted to $4.7 million in Q3 2025, which was down 3584.37% from $4.7 million recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Long-Term Deferred Tax peaked at $7.4 million during Q3 2024, and registered a low of $481000.0 during Q2 2021.
  • For the 3-year period, Bioventus' Long-Term Deferred Tax averaged around $3.5 million, with its median value being $4.7 million (2024).
  • Examining YoY changes over the last 5 years, Bioventus' Long-Term Deferred Tax showed a top increase of 3107.21% in 2025 and a maximum decrease of 3584.37% in 2025.
  • Over the past 3 years, Bioventus' Long-Term Deferred Tax (Quarter) stood at $481000.0 in 2021, then skyrocketed by 886.49% to $4.7 million in 2024, then changed by 0.0% to $4.7 million in 2025.
  • Its Long-Term Deferred Tax was $4.7 million in Q3 2025, compared to $4.7 million in Q2 2025 and $4.7 million in Q1 2025.